Reflect Scientific Inc (RSCF)
OTHER OTC:RSCF
Top Page
No summary available
Positive Factors
Revenue Growth
Reflect Scientific's strong revenue growth indicates increasing demand for its products, suggesting effective market penetration and potential for future expansion.
Negative Factors
Cash Flow Issues
Negative cash flow reflects liquidity challenges, potentially limiting the company's ability to invest in growth and meet short-term obligations.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Reflect Scientific's strong revenue growth indicates increasing demand for its products, suggesting effective market penetration and potential for future expansion.
Read all positive factors
Reflect Scientific (RSCF) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.82M
Dividend YieldN/A
Average Volume (3M)107.91K
Price to Earnings (P/E)28.5
Beta (1Y)1.32
Revenue Growth43.30%
EPS GrowthN/A
CountryUS
Employees7
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)<0.01
Shares Outstanding85,664,085
10 Day Avg. Volume146,475
30 Day Avg. Volume107,914
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.99
Price to Sales (P/S)5.25
P/FCF Ratio-54.50
Enterprise Value/Market Cap0.49
Enterprise Value/Revenue1.28
Enterprise Value/Gross Profit2.28
Enterprise Value/Ebitda6.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Reflect Scientific Business Overview & Revenue Model
Company Description
Reflect Scientific, Inc. designs, develops, and sells scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra low temperature and blast freezers, which are used to store various product...
How the Company Makes Money
Reflect Scientific generates revenue primarily through the sale of its specialized refrigeration and cryogenic cooling systems. These products cater to a niche market that requires precise temperature control for research, storage, and transportat...
Reflect Scientific Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Dec 2023 | Mar 2023 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.47M | 1.08M | 2.04M | 2.81M | 2.79M | 1.61M |
| Gross Profit | 828.57K | 596.42K | 1.22M | 1.93M | 1.72M | 991.64K |
| EBITDA | 309.24K | -405.78K | 146.32K | 884.96K | 713.35K | -190.85K |
| Net Income | 274.85K | -459.03K | 89.40K | 939.07K | 660.12K | -196.34K |
Balance Sheet | ||||||
| Total Assets | 2.34M | 2.67M | 2.45M | 2.48M | 1.68M | 1.08M |
| Cash, Cash Equivalents and Short-Term Investments | 1.08M | 1.28M | 1.38M | 1.47M | 642.54K | 555.16K |
| Total Debt | 160.99K | 242.64K | 57.39K | 113.84K | 279.36K | 67.61K |
| Total Liabilities | 217.61K | 776.33K | 149.59K | 299.24K | 463.31K | 525.75K |
| Stockholders Equity | 2.12M | 1.89M | 2.30M | 2.18M | 1.21M | 553.03K |
Cash Flow | ||||||
| Free Cash Flow | -4.89K | -103.98K | -92.00K | 831.38K | -25.22K | 335.87K |
| Operating Cash Flow | -4.88K | -103.98K | -92.00K | 831.38K | -25.22K | 335.87K |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 0.00 | 2.25K | 27.50K | 112.60K | -1.14K |
Reflect Scientific Technical Analysis
Negative
0.04
Price Trends
0.05
Negative
0.05
Negative
0.06
Negative
Market Momentum
>-0.01
Positive
6.45
Positive
-8.89
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RSCF, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 6.45 is Positive, neither overbought nor oversold. The STOCH value of -8.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RSCF.
Reflect Scientific Peers Comparison
UnderperformOutperform
Sector (51)
RSCF
Reflect Scientific
0.04
>-0.01
-6.38%
GCTK
GlucoTrack
0.99
-9.48
-90.54%
LUCY
Innovative Eyewear, Inc.
1.08
-1.52
-58.46%
WOK
WORK Medical Technology Group LTD
1.14
-5,697.86
-99.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―